bromfenac ophthalmic solution 0.09%
BROMFENAC SODIUM (bromfenac ophthalmic solution 0.09%) is anti-inflammatory drug (nsaid) that has anti-inflammatory activity. Approved for postoperative inflammation, reduction of ocular pain in patients. First approved in 2019.
Drug data last refreshed 8h ago
anti-inflammatory drug (NSAID) that has anti-inflammatory activity. The mechanism of its action is thought to be due to its ability to block prostaglandin synthesis by inhibiting cyclooxygenase 1 and 2. Prostaglandins have been shown in many animal models to be mediators of certain kinds of…
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Comparing Post-intravitreal Injection Pain Scores Using Loteprednol, Bromfenac Sodium, and Artificial Tears Over a 24-hour Period